Gary B. Kaplan - Publications

University of Rhode Island, Providence, RI, United States 
Neuroscience Biology, Pharmacology

53 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Kaplan GB, Leite-Morris KA, Wang L, Rumbika KK, Heinrichs SC, Zeng X, Wu L, Arena DT, Teng YD. PATHOPHYSIOLOGICAL BASES OF COMORBIDITY: TBI AND PTSD. Journal of Neurotrauma. PMID 29017388 DOI: 10.1089/neu.2016.4953  1
2017 Kobrin KL, Arena DT, Heinrichs SC, Nguyen OH, Kaplan GB. Dopamine D1 receptor agonist treatment attenuates extinction of morphine conditioned place preference while increasing dendritic complexity in the nucleus accumbens core. Behavioural Brain Research. PMID 28089852 DOI: 10.1016/j.bbr.2017.01.011  0.48
2015 Kobrin KL, Moody O, Arena DT, Moore CF, Heinrichs SC, Kaplan GB. Acquisition of morphine conditioned place preference increases the dendritic complexity of nucleus accumbens core neurons. Addiction Biology. PMID 26096355 DOI: 10.1111/adb.12273  1
2014 Liverant GI, Sloan DM, Pizzagalli DA, Harte CB, Kamholz BW, Rosebrock LE, Cohen AL, Fava M, Kaplan GB. Associations among smoking, anhedonia, and reward learning in depression. Behavior Therapy. 45: 651-63. PMID 25022776 DOI: 10.1016/j.beth.2014.02.004  1
2014 Leite-Morris KA, Kobrin KL, Guy MD, Young AJ, Heinrichs SC, Kaplan GB. Extinction of opiate reward reduces dendritic arborization and c-Fos expression in the nucleus accumbens core. Behavioural Brain Research. 263: 51-9. PMID 24406724 DOI: 10.1016/j.bbr.2013.12.041  1
2013 Heinrichs SC, Leite-Morris KA, Rasmusson AM, Kaplan GB. Repeated valproate treatment facilitates fear extinction under specific stimulus conditions. Neuroscience Letters. 552: 108-13. PMID 23916657 DOI: 10.1016/j.neulet.2013.07.035  1
2013 Heinrichs SC, Leite-Morris KA, Guy MD, Goldberg LR, Young AJ, Kaplan GB. Dendritic structural plasticity in the basolateral amygdala after fear conditioning and its extinction in mice. Behavioural Brain Research. 248: 80-4. PMID 23570859 DOI: 10.1016/j.bbr.2013.03.048  1
2013 Harte CB, Liverant GI, Sloan DM, Kamholz BW, Rosebrock LE, Fava M, Kaplan GB. Association between smoking and heart rate variability among individuals with depression. Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine. 46: 73-80. PMID 23436273 DOI: 10.1007/s12160-013-9476-8  1
2013 Nic Dhonnchadha BÁ, Lin A, Leite-Morris KA, Kaplan GB, Man HY, Kantak KM. Alterations in expression and phosphorylation of GluA1 receptors following cocaine-cue extinction learning. Behavioural Brain Research. 238: 119-23. PMID 23085477 DOI: 10.1016/j.bbr.2012.10.012  1
2013 Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Ahnallen CG. Separate and combined effects of very low nicotine cigarettes and nicotine replacement in smokers with schizophrenia and controls. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 15: 121-9. PMID 22517190 DOI: 10.1093/ntr/nts098  1
2012 Nic Dhonnchadha BÁ, Lovascio BF, Shrestha N, Lin A, Leite-Morris KA, Man HY, Kaplan GB, Kantak KM. Changes in expression of c-Fos protein following cocaine-cue extinction learning. Behavioural Brain Research. 234: 100-6. PMID 22721675 DOI: 10.1016/j.bbr.2012.06.010  1
2012 Ahnallen CG, Liverant GI, Gregor KL, Kamholz BW, Levitt JJ, Gulliver SB, Pizzagalli DA, Koneru VK, Kaplan GB. The relationship between reward-based learning and nicotine dependence in smokers with schizophrenia. Psychiatry Research. 196: 9-14. PMID 22342123 DOI: 10.1016/j.psychres.2011.09.011  1
2011 Kaplan GB, Leite-Morris KA, Fan W, Young AJ, Guy MD. Opiate sensitization induces FosB/ΔFosB expression in prefrontal cortical, striatal and amygdala brain regions. Plos One. 6: e23574. PMID 21886798 DOI: 10.1371/journal.pone.0023574  1
2011 Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Reid N. Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia. Psychopharmacology. 217: 279-87. PMID 21475970 DOI: 10.1007/s00213-011-2282-8  1
2011 Kaplan GB, Moore KA. The use of cognitive enhancers in animal models of fear extinction. Pharmacology, Biochemistry, and Behavior. 99: 217-28. PMID 21256147 DOI: 10.1016/j.pbb.2011.01.009  1
2011 Kaplan GB, Heinrichs SC, Carey RJ. Treatment of addiction and anxiety using extinction approaches: neural mechanisms and their treatment implications. Pharmacology, Biochemistry, and Behavior. 97: 619-25. PMID 20723558 DOI: 10.1016/j.pbb.2010.08.004  1
2010 Kaplan GB, Vasterling JJ, Vedak PC. Brain-derived neurotrophic factor in traumatic brain injury, post-traumatic stress disorder, and their comorbid conditions: role in pathogenesis and treatment. Behavioural Pharmacology. 21: 427-37. PMID 20679891 DOI: 10.1097/FBP.0b013e32833d8bc9  1
2010 Sirota AD, Rohsenow DJ, Mackinnon SV, Martin RA, Eaton CA, Kaplan GB, Monti PM, Tidey JW, Swift RM. Intolerance for Smoking Abstinence Questionnaire: psychometric properties and relationship to tobacco dependence and abstinence. Addictive Behaviors. 35: 686-93. PMID 20381260 DOI: 10.1016/j.addbeh.2010.02.014  1
2010 Heinrichs SC, Leite-Morris KA, Carey RJ, Kaplan GB. Baclofen enhances extinction of opiate conditioned place preference. Behavioural Brain Research. 207: 353-9. PMID 19840820 DOI: 10.1016/j.bbr.2009.10.013  1
2009 Kaplan GB, Leite-Morris KA, Klufas MA, Fan W. Intra-VTA adenosine A1 receptor activation blocks morphine stimulation of motor behavior and cortical and limbic Fos immunoreactivity. European Journal of Pharmacology. 602: 268-76. PMID 19027733 DOI: 10.1016/j.ejphar.2008.10.052  1
2008 Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Adolfo AB. Effects of smoking abstinence, smoking cues and nicotine replacement in smokers with schizophrenia and controls. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 10: 1047-56. PMID 18584468 DOI: 10.1080/14622200802097373  1
2007 Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, MacKinnon SV, Sirota AD, Kaplan GB. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking. Experimental and Clinical Psychopharmacology. 15: 81-92. PMID 17295587 DOI: 10.1037/1064-1297.15.1.81  1
2006 Kaplan GB, Phillips KA, Vaccaro A, Eisen JL, Posternak MA, MacAskill HS. Assessment of insight into delusional beliefs in schizophrenia using the Brown Assessment of Beliefs Scale. Schizophrenia Research. 82: 279-81. PMID 16406495 DOI: 10.1016/j.schres.2005.11.009  1
2006 Epstein-Lubow G, Hochstadt J, Lieberman P, Kaplan GB. Speech production in schizophrenia: preliminary data regarding voice onset time. Schizophrenia Research. 82: 267-9. PMID 16371248 DOI: 10.1016/j.schres.2005.11.005  1
2005 Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM. Subjective and physiological responses to smoking cues in smokers with schizophrenia. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 7: 421-9. PMID 16085510 DOI: 10.1080/14622200500125724  1
2005 Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM. Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls. Drug and Alcohol Dependence. 80: 259-65. PMID 15869844 DOI: 10.1016/j.drugalcdep.2005.04.002  1
2004 Kaplan GB, McRoberts RL, Smokler HJ. Baclofen as adjunctive treatment for a patient with cocaine dependence and schizoaffective disorder. Journal of Clinical Psychopharmacology. 24: 574-5. PMID 15349029 DOI: 10.1097/  1
2004 Turalba AV, Leite-Morris KA, Kaplan GB. Antipsychotics regulate cyclic AMP-dependent protein kinase and phosphorylated cyclic AMP response element-binding protein in striatal and cortical brain regions in mice. Neuroscience Letters. 357: 53-7. PMID 15036612 DOI: 10.1016/j.neulet.2003.11.059  1
2004 Leite-Morris KA, Fukudome EY, Shoeb MH, Kaplan GB. GABA(B) receptor activation in the ventral tegmental area inhibits the acquisition and expression of opiate-induced motor sensitization. The Journal of Pharmacology and Experimental Therapeutics. 308: 667-78. PMID 14610238 DOI: 10.1124/jpet.103.058412  1
2003 Kaplan GB, Leite-Morris KA, Joshi M, Shoeb MH, Carey RJ. Baclofen inhibits opiate-induced conditioned place preference and associated induction of Fos in cortical and limbic regions. Brain Research. 987: 122-5. PMID 14499954 DOI: 10.1016/S0006-8993(03)03218-9  1
2002 Leite-Morris KA, Fukudome EY, Kaplan GB. Opiate-induced motor stimulation is regulated by gamma-aminobutyric acid type B receptors found in the ventral tegmental area in mice. Neuroscience Letters. 317: 119-22. PMID 11755254 DOI: 10.1016/S0304-3940(01)02457-0  1
2001 Kaplan GB, Turalba AV. Acute antipsychotic treatment increases cyclic AMP-dependent protein kinase levels in dopaminergic brain regions Clinical Pharmacology and Therapeutics. 69.  1
2000 Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, Colby SM, Kaplan GB. Naltrexone's effects on reactivity to alcohol cues among alcoholic men. Journal of Abnormal Psychology. 109: 738-42. PMID 11195999 DOI: 10.1037//0021-843X.109.4.738  1
2000 Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Harmatz JS, Shader RI. Differences in pharmacodynamics but not pharmacokinetics between subjects with panic disorder and healthy subjects after treatment with a single dose of alprazolam. Journal of Clinical Psychopharmacology. 20: 338-46. PMID 10831021 DOI: 10.1097/00004714-200006000-00008  1
1999 Kaplan GB, Bharmal NH, Leite-Morris KA, Adams WR. Role of adenosine A1 and A2A receptors in the alcohol withdrawal syndrome. Alcohol (Fayetteville, N.Y.). 19: 157-62. PMID 10548160 DOI: 10.1016/S0741-8329(99)00033-6  1
1999 Kaplan GB, Leite-Morris KA, Keith DJ. Differential effects of treatment with typical and atypical antipsychotic drugs on adenylyl cyclase and G proteins. Neuroscience Letters. 273: 147-50. PMID 10515180 DOI: 10.1016/S0304-3940(99)00610-2  1
1999 Weisberg SP, Kaplan GB. Adenosine receptor antagonists inhibit the development of morphine sensitization in the C57BL/6 mouse Neuroscience Letters. 264: 89-92. PMID 10320021 DOI: 10.1016/S0304-3940(99)00188-3  1
1999 Kaplan GB, Weisberg SP. Adenosine receptor antagonists inhibit the expression of opiate-induced locomotor sensitization in mice Clinical Pharmacology and Therapeutics. 65: 155.  1
1998 Kaplan GB, Coyle TS. Adenosine kinase inhibitors attenuate opiate withdrawal via adenosine receptor activation European Journal of Pharmacology. 362: 1-8. PMID 9865523 DOI: 10.1016/S0014-2999(98)00724-9  1
1998 Leite-Morris KA, Kaplan GB, Smith JG, Sears MT. Regulation of G proteins and adenylyl cyclase in brain regions of caffeine-tolerant and -dependent mice. Brain Research. 804: 52-62. PMID 9729274 DOI: 10.1016/S0006-8993(98)00582-4  1
1998 Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Harmatz JS, Shader RI. Single-dose pharmacokinetics and pharmacodynamics of alprazolam in elderly and young subjects. Journal of Clinical Pharmacology. 38: 14-21. PMID 9597554  1
1998 Kaplan GB, Sethi RK, McClelland EG, Leite-Morris KA. Regulation of G protein-mediated adenylyl cyclase in striatum and cortex of opiate-dependent and opiate withdrawing mice. Brain Research. 788: 104-10. PMID 9554971 DOI: 10.1016/S0006-8993(97)01524-2  1
1997 Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Cotreau MM, Harmatz JS, Shader RI. Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. Journal of Clinical Pharmacology. 37: 693-703. PMID 9378841  1
1997 Kaplan GB, Leite-Morris KA. Up-regulation of adenosine transporter-binding sites in striatum and hypothalamus of opiate tolerant mice. Brain Research. 763: 215-20. PMID 9296562 DOI: 10.1016/S0006-8993(97)00413-7  1
1996 Kaplan GB, Sears MT. Adenosine receptor agonists attenuate and adenosine receptor antagonists exacerbate opiate withdrawal signs Psychopharmacology. 123: 64-70. PMID 8741956  1
1994 Kaplan GB, Leite-Morris KA, Sears MT. Alterations of adenosine A1 receptors in morphine dependence. Brain Research. 657: 347-50. PMID 7820640 DOI: 10.1016/0006-8993(94)90990-3  1
1993 Kaplan GB, Greenblatt DJ, Kent MA, Cotreau-Bibbo MM. Caffeine treatment and withdrawal in mice: relationships between dosage, concentrations, locomotor activity and A1 adenosine receptor binding. The Journal of Pharmacology and Experimental Therapeutics. 266: 1563-72. PMID 8371158  1
1992 Kaplan GB, Greenblatt DJ, Kent MA, Cotreau MM, Arcelin G, Shader RI. Caffeine-induced behavioral stimulation is dose-dependent and associated with A1 adenosine receptor occupancy. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 6: 145-53. PMID 1599605  1
1992 KAPLAN GB, COTREAU MM, GREENBLATT DJ. Effects of benzodiazepine administration on A1 adenosine receptor binding in‐vivo and ex‐vivo Journal of Pharmacy and Pharmacology. 44: 700-703. PMID 1359103 DOI: 10.1111/j.2042-7158.1992.tb05502.x  1
1990 Kaplan GB, Tai NT, Greenblatt DJ, Shader RI. Caffeine-induced behavioural stimulation is dose- and concentration-dependent British Journal of Pharmacology. 100: 435-440. PMID 2390669  1
1990 Kaplan GB, Tai NT, Greenblatt DJ, Shader RI. Separate and combined effects of caffeine and alprazolam on motor activity and benzodiazepine receptor binding in vivo Psychopharmacology. 101: 539-544. PMID 2167493 DOI: 10.1007/BF02244234  1
1989 Kaplan GB, Greenblatt DJ, Leduc BW, Thompson ML, Shader RI. Relationship of plasma and brain concentrations of caffeine and metabolites to benzodiazepine receptor binding and locomotor activity Journal of Pharmacology and Experimental Therapeutics. 248: 1078-1083. PMID 2539455  1
1989 Lopez F, Miller LG, Greenblatt DJ, Kaplan GB, Shader RI. Interaction of caffeine with the GABAA receptor complex: alterations in receptor function but not ligand binding European Journal of Pharmacology: Molecular Pharmacology. 172: 453-459. PMID 2482188 DOI: 10.1016/0922-4106(89)90028-X  1
Show low-probability matches.